ReviewDiagnostics (Basel, Switzerland)2026
Bridging the Artificial Intelligence Translation Gap in Perioperative Pulmonary and Respiratory Complications: A Practical Framework for Institution-Level Implementation.
Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Perioperative pulmonary and respiratory complications (PPRCs) result in increased morbidity, mortality, and healthcare costs. Recent research has focused on employing artificial intelligence (AI) and machine learning to predict and analyze PPRCs using expansive perioperative datasets. Despite advances in feature engineering, deep learning architectures, and explainable AI, models are rarely implemented in routine clinical practice. In this narrative review, we synthesize evidence from 59 unique publications, corresponding to 63 phenotype-specific study-listings across six PPRC phenotypes (combined postoperative pulmonary complications, pneumonia/pulmonary infection, hypoxemia, respiratory failure, pulmonary embolism/venous thromboembolism, and pulmonary edema) and introduce an integrated analytical and translational framework to bridge translation gap. The proposed paradigm comprises a tiered framework for evaluating outcome ascertainment quality (TIER) (39 of 63 study-listings [61.9%] were classified as TIER A according to the proposed framework), an algorithm-cohort-phenotype fit model, a discrimination-calibration-utility triad for performance assessment, a translation gap framework highlighting interacting challenges across validation, deployment, and evidence generation, and a six-step framework for clinical translation. Most models lacked robust validation, with only 9 of the 59 unique publications (15.3%) reporting true cross-institutional external validation, thereby limiting their generalizability. Near-term clinical translation is more likely through institution-specific development and local adaptation than direct widespread deployment, supported by concrete recommendations for clinicians.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.